{"id":829,"date":"2022-09-14T07:00:03","date_gmt":"2022-09-14T05:00:03","guid":{"rendered":"https:\/\/neuro-x.epfl.ch\/en\/news\/scientists-decode-the-neural-signals-that-encode-walking-in-the-brain\/"},"modified":"2024-12-10T17:25:54","modified_gmt":"2024-12-10T15:25:54","slug":"scientists-decode-the-neural-signals-that-encode-walking-in-the-brain","status":"publish","type":"news","link":"https:\/\/neuro-x.epfl.ch\/en\/news\/scientists-decode-the-neural-signals-that-encode-walking-in-the-brain\/","title":{"rendered":"Scientists decode the neural signals that encode walking in the brain"},"content":{"rendered":"<p>Deep brain stimulation of the subthalamic nucleus is a well-established neuromodulation therapy for the symptomatic treatment of motor deficits in Parkinson\u2019s disease. For decades, this therapy has been optimized to alleviate symptoms such as tremor, bradykinesia (slowness of movements) and rigidity. However, deep brain stimulation often fails to improve, or can even aggravate gait deficits. To date, little is known about the neural activity patterns underlying gait deficits in Parkinson\u2019s disease, which has restricted the development of neuromodulation therapies better targeting these impairments.<\/p>\n<p>In this study, we leveraged a high-resolution gait platform established at CHUV to record the activity of the subthalamic nuclei, wirelessly and in real time, and to map it to whole-body movements and leg muscle activity while patients performed a series of walking tasks. We identified the neural activity patterns underlying basic walking, turning and freezing of gait. We then developed machine learning algorithms able to predict in real-time different aspects of walking, such as locomotor states, gait phases or effort modulations when avoiding obstacles, as well as pathological episodes such as freezing of gait.<\/p>\n<p>These results open new avenues for the development of adaptive neuromodulation therapies that employ predictions of leg motor states in real time to target and prevent gait and balance deficits in people with Parkinson\u2019s disease.<\/p>\n<p>Link to the article: <a href=\"https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.abo1800\">https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.abo1800<\/a><\/p>\n<p><strong>Contact information: <\/strong>Eduardo Martin Moraud eduardo.martin-moraud@chuv.ch<\/p>\n<div style=\"background:#eeeeee;border:1px solid #cccccc;padding:5px 10px\"><strong>About .NeuroRestore<\/strong><br \/> <a href=\"https:\/\/www.neurorestore.swiss\/\">.NeuroRestore<\/a> is an R&amp;D platform based in French-speaking Switzerland that develops approaches for restoring neurological function in patients suffering from paraplegia, tetraplegia, Parkinson\u2019s disease or the consequences of stroke. It is headed by Gr\u00e9goire Courtine, a neuroscientist at Ecole polytechnique f\u00e9d\u00e9ral de Lausanne (EPFL), and Jocelyne Bloch, a neurosurgeon at Lausanne University Hospital (CHUV). .NeuroRestore, founded in 2018, brings together engineers, doctors and scientists from EPFL, CHUV and the University of Lausanne, with the support of the Defitech Foundation. It draws on this pooled expertise to develop neurotherapies that can help patients recover motor function. Its innovative and personalized treatments are tested through research protocols and then made available to hospitals and patients. .NeuroRestore is also committed to training the next generation of health-care professionals and engineers on the use of these novel therapeutic approaches.<\/div><\/p>\n","protected":false},"featured_media":830,"template":"","project":[],"faculty":[31],"public":[27,28,30,25,29,26],"themes":[24],"news-category":[23],"class_list":["post-829","news","type-news","status-publish","has-post-thumbnail","hentry","faculty-sv","public-collaborators","public-industries-partners","public-media","public-prospective-students","public-public","public-students","themes-health","news-category-research"],"_links":{"self":[{"href":"https:\/\/neuro-x.epfl.ch\/en\/wp-json\/wp\/v2\/news\/829","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neuro-x.epfl.ch\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/neuro-x.epfl.ch\/en\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neuro-x.epfl.ch\/en\/wp-json\/wp\/v2\/media\/830"}],"wp:attachment":[{"href":"https:\/\/neuro-x.epfl.ch\/en\/wp-json\/wp\/v2\/media?parent=829"}],"wp:term":[{"taxonomy":"project","embeddable":true,"href":"https:\/\/neuro-x.epfl.ch\/en\/wp-json\/wp\/v2\/project?post=829"},{"taxonomy":"faculty","embeddable":true,"href":"https:\/\/neuro-x.epfl.ch\/en\/wp-json\/wp\/v2\/faculty?post=829"},{"taxonomy":"public","embeddable":true,"href":"https:\/\/neuro-x.epfl.ch\/en\/wp-json\/wp\/v2\/public?post=829"},{"taxonomy":"themes","embeddable":true,"href":"https:\/\/neuro-x.epfl.ch\/en\/wp-json\/wp\/v2\/themes?post=829"},{"taxonomy":"news-category","embeddable":true,"href":"https:\/\/neuro-x.epfl.ch\/en\/wp-json\/wp\/v2\/news-category?post=829"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}